Therapeutic drug monitoring in inflammatory bowel disease


CATAG has developed this document to facilitate and support the translation of best available evidence into practice for the management of patients with inflammatory bowel disease. The document summarises the evidence on the use of therapeutic drug monitoring of biologics as of May 2021. This will assist good governance and decision-making for health service organisations, medicines governance committees and health professionals. It can be used in conjunction with formulary decisions and recommendations.

Download resource

Download (620.49 KB, PDF)

Published date

30 November 2021

Resource type

Evidence into practice

Governance topic